outperform price
thesi updat although new york medicaid cut
increment disappoint last night
guidanc updat wellcar acquisit
wash asid post-sup tuesday surg
stock morn confer call manag
said half gross cut reduct
premium rate half halt qualiti bonu
payment disproportion hurt
highest score expect net neg
ep impact annual number retroact jan
compani still hope get least
cut roll back ny health plan rais actuari
sound concern though also note state also
look medicaid cut help fill big
deficit fiscal budget must pass
april compani also confirm
redeploy after-tax proce
wcg divestitur plan mix share repo debt
paydown maintain debt/cap ratio could
increment boost least meanwhil accret
synergi target wellcar unchang still
see upsid potenti well multipl recoveri
reiter outperform rate tweak
estim price target modestli reflect
new york medicaid cut
pleas see analyst certif import disclosur page report evercor isi affili seek busi
compani cover research report investor awar firm may conflict interest could affect object
report investor consid report singl factor make invest decis
valuat methodolog base mix discount cash flow analysi rel valuat multipl
risk valuat includ regulatori risk overal market risk well unforeseen event relat individu cover
compani broader sector includ new competit product technolog
laboratori corp america
articl articl
time dissemin march pm et
analyst suzi yoon michael newshel primarili respons prepar research report attest follow
view opinion render research report reflect person view subject compani issuer part
research analyst compens directli relat specif recommend view research report
